Skip to main content

Table 2 Univariate and multivariate logistic regression predictors of interlobar lymph node metastasis

From: Clinicopathologic predictors of metastasis of different regional lymph nodes in patients intraoperatively diagnosed with stage-I non-small cell lung cancer

Independents Variables

Univariate Predictors

Multivariate Predictors

N Metastasis/N total

Odds Ratio (95% CI), P-value

B

Odds Ratio (95% CI), P-value

Age (years)

 ≤60

19/216 (8.8%)

Reference

  

 > 60

10/202 (5.0%)

0.54 (0.25–1.19), 0.540

  

Sex

 Female

10/207 (4.8%)

Reference

  

 Male

19/211 (9.0%)

1.95 (0.88–4.30), 0.098*

  

Maximum diameter of tumor

 ≤1.6 cm

8/205 (3.9%)

Reference

  

 > 1.6 cm

21/209 (10.0%)

2.75 (1.19–6.36), 0.018*

  

Position

 

< 0.0001*

  

 Right Upper Lobe

3/121 (2.5%)

Reference

  

 Right Middle Lobe

0/22 (0.0%)

0.00 (0.00-), 0.998

  

 Right Lower Lobe

16/61 (26.2%)

13.99 (3.89–50.30), < 0.0001*

  

 Left Upper Lobe

1/93 (1.1%)

0.43 (0.04–4.18), 0.465

  

 Left Lower Lobe

6/67 (9.0%)

3.87 (0.94–16.01), 0.062*

  

 Ipsilateral Mixed lobes

1/35 (2.9%)

1.16 (0.12–11.48), 0.901

  

 Bilateral Mixed lobes

2/17 (11.8%)

5.24 (0.81–33.96), 0.082*

  

Pathological type

 Adenocarcinoma

25/319 (7.8%)

Reference

  

 Others

4/98 (4.1%)

0.50 (0.17–1.48), 0.209

  

Tumor differentiation

 No

0/102 (0.0%)

Reference

  

 Yes

29/302 (9.6%)

171,607,233.80 (0.00-), 0.996

  

Pathological morphology

 No

8/140 (5.7%)

Reference

  

 Yes

21/262 (8.0%)

1.44 (0.62–3.34), 0.398

  

Pulmonary membrane invasion

 No

14/296 (4.7%)

Reference

  

 Yes

5/40 (12.5%)

2.88 (0.98–8.47), 0.055*

  

Bronchial mucosa and cartilage invasion

 No

23/379 (6.1%)

Reference

  

 Yes

6/39 (15.4%)

2.81 (1.07–7.40), 0.036*

  

Vascular invasion

 No

25/387 (6.5%)

Reference

  

 Yes

4/30 (13.3%)

2.23 (0.72–6.88), 0.164*

  

Nerve invasion

 No

28/412 (6.8%)

Reference

  

 Yes

1/6 (16.7%)

2.74 (0.31–24.29), 0.365

  

CEA

 ≤2.21 ng/ml

4/172 (2.3%)

Reference

  

 > 2.21 ng/ml

18/182 (9.9%)

4.61 (1.53–13.91), 0.007*

  

Albumin

 ≤43.1 g/l

22/195 (11.3%)

Reference

  

 > 43.1 g/l

7/212 (3.3%)

0.27 (0.11–0.64), 0.003*

  
  1. *Only variables with P value less than 0.20 were included in the multivariate analysis